ResearcherYokohama City UniversityNo recent work listed
Keiichi Yazawa
Matched on OpenAlex author ID A5090026648. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2020: 1 paper · 2021: none · 2022: 1 paper
Papers 2
- CRMP4 Up-regulates M2 Macrophages and Myeloid-derived Suppressor Cells to Promote Pancreatic Cancer in Mice. Co-author DOI 10.21873/anticanres.15537↗
- Low Incidence of High-Grade Pancreatic Intraepithelial Neoplasia Lesions in a Crmp4 Gene-Deficient Mouse Model of Pancreatic Cancer. Co-author DOI 10.1016/j.tranon.2020.100746↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yasuhiro Yabushita · 2 shared papers, 2020–2022 · strength 0.25
- Paper CRMP4 Up-regulates M2 Macrophages and Myeloid-derived Suppressor Cells to Promote Pancreatic Cancer in Mice. DOI 10.21873/anticanres.15537↗
- Paper Low Incidence of High-Grade Pancreatic Intraepithelial Neoplasia Lesions in a Crmp4 Gene-Deficient Mouse Model of Pancr… DOI 10.1016/j.tranon.2020.100746↗
- Yukihiko Hiroshima · 2 shared papers, 2020–2022 · strength 0.25
- Paper CRMP4 Up-regulates M2 Macrophages and Myeloid-derived Suppressor Cells to Promote Pancreatic Cancer in Mice. DOI 10.21873/anticanres.15537↗
- Paper Low Incidence of High-Grade Pancreatic Intraepithelial Neoplasia Lesions in a Crmp4 Gene-Deficient Mouse Model of Pancr… DOI 10.1016/j.tranon.2020.100746↗
- Itaru Endo · 2 shared papers, 2020–2022 · strength 0.25
- Paper CRMP4 Up-regulates M2 Macrophages and Myeloid-derived Suppressor Cells to Promote Pancreatic Cancer in Mice. DOI 10.21873/anticanres.15537↗
- Paper Low Incidence of High-Grade Pancreatic Intraepithelial Neoplasia Lesions in a Crmp4 Gene-Deficient Mouse Model of Pancr… DOI 10.1016/j.tranon.2020.100746↗
- Yuki Homma · 1 shared paper, 2022 · strength 0.15
- Yuzo Minegishi · 1 shared paper, 2022 · strength 0.15
- Hideki Taniguchi · 1 shared paper, 2020 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.